GL1X · GenesisL1 explorer

Research workbench

Crystal structure of the di-domain ARO/CYC stfq from the steffimycin biosynthetic pathway

Analyse Crystal structure of the di-domain ARO/CYC stfq from the steffimycin… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4XRT
Type
protein
Length
601 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Stfq AROMATASE/CYCLASE
UniProt
Q2PA00
Pockets
6 · best druggability 0.82

Structure

x-ray diffraction · 2 distinct chains · 32% helix, 46% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AStfq AROMATASE/CYCLASEprotein30231% helix, 47% strandQ2PA00
BStfq AROMATASE/CYCLASEprotein29932% helix, 45% strandQ2PA00

Ligands and binding sites

  • FMT · Formic acid · additive · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

6 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
111240.820.83139FMT
23900.710.8237empty
3990.410.7724empty
4830.350.7512empty
5500.350.7913empty

Interfaces

1 interface between chains.

  • A–B · 645 Ų buried · 14 hydrogen bonds · protein-protein

Compared structures

  • 4XRT · Crystal structure of the di-domain ARO/CYC StfQ from the steffimycin biosynthetic pathway · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.